vantocil has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SJ; Jeon, D; Kim, HY; Kim, IH; Kim, KC; Kim, MS; Kim, SH; Lee, K; Park, CM; Shin, YJ | 1 |
| Bionda, N; McMahon, RE; Poleon, S; Salamone, AB; Salamone, JC | 1 |
| Assadian, O; Diedrich, S; Heidecke, CD; Kramer, A; Müller, G; Papke, R; Parteke, LI; Sandbrink, C; van der Linde, J | 1 |
| Assadian, O; Dissemond, J; Eberlein, T; Kramer, A; Müller, G | 1 |
| Cha, H; Cho, JM; Kim, HJ; Kim, HR; Kim, YS | 1 |
| Arici, MK; Dursun, A; Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
| Davis, SC; Gil, J; Harding, A; Higa, A; Parajon, F; Solis, M; Valdes, J | 1 |
| Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
| Ballet, JJ; Benichou, J; Brasseur, G; Duclos, C; Favennec, L; François, A; Gargala, G; Hellot, MF; Muraine, M; Vasseneix, C | 1 |
| Frieling, H; Gründling, M; Kanellopoulou, T; Lauer, KS; Lehmann, C; Meissner, K; Pavlovic, D; Usichenko, T; Wendt, M | 1 |
| Easty, DL; Ruddell, TJ | 1 |
| Chandler, JW; Fiscella, RG; Messick, CR; Moshifar, M; Pendland, SL; Viana, M | 1 |
| Essary, LR; Fleming, TP; Garcia-Ferrer, FJ; Goldberg, MA; Laycock, KA; Pepose, JS; Tarle, IS; Valluri, S | 1 |
13 other study(ies) available for vantocil and Disease Models, Animal
| Article | Year |
|---|---|
Anti-fibrotic effect of pycnogenol® in a polyhexamethylene guanidine-treated mouse model.
Topics: Animals; Anti-Inflammatory Agents; Biguanides; Disease Models, Animal; Flavonoids; Inflammation; Male; Mice; Mice, Inbred C57BL; Plant Extracts; Pulmonary Fibrosis | 2022 |
Efficacy of Wound Cleansers on Wound-Specific Organisms Using In Vitro and Ex Vivo Biofilm Models.
Topics: Animals; Biguanides; Biofilms; Detergents; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Silver; Sodium Hypochlorite; Swine; Wound Healing | 2020 |
Efficiency of Emulsified Particle-Associated Polyhexamethylenbiguanid-Hydrochlorid (Polihexanide) for Peritoneal Lavage in a Murine Sepsis Model.
Topics: Animals; Bacterial Load; Biguanides; Cytokines; Disease Models, Animal; Disinfectants; Female; Mice; Mice, Inbred C57BL; Peritoneal Lavage; Peritonitis; Sepsis | 2018 |
Re-evaluation of polihexanide use in wound antisepsis in order to clarify ambiguities of two animal studies.
Topics: Animals; Anti-Infective Agents, Local; Biguanides; Consensus; Disease Models, Animal; Risk Assessment; Surgical Wound Infection; Wound Healing | 2019 |
The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models.
Topics: Animals; Biguanides; Bleomycin; Disease Models, Animal; Epithelial-Mesenchymal Transition; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Mice; Pyridones; Republic of Korea | 2019 |
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Biguanides; Cell Line; Cell Proliferation; Disease Models, Animal; Disinfectants; Drug Therapy, Combination; Fibroblasts; Male; Phosphorylcholine; Rats; Rats, Wistar | 2014 |
Effectiveness of a polyhexanide irrigation solution on methicillin-resistant Staphylococcus aureus biofilms in a porcine wound model.
Topics: Animals; Betaine; Biguanides; Biofilms; Disease Models, Animal; Disinfectants; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Swine; Wounds and Injuries | 2017 |
Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Cricetinae; Disease Models, Animal; Humans; Male; Mesocricetus; Phosphorylcholine; Treatment Outcome | 2012 |
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Betamethasone; Biguanides; Chronic Disease; Corneal Stroma; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Glucocorticoids; Male; Parasitic Sensitivity Tests; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2006 |
Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia.
Topics: Animals; Anti-Infective Agents, Local; Biguanides; Disease Models, Animal; Endotoxemia; Gastrointestinal Motility; Instillation, Drug; Intestines; Lipopolysaccharides; Male; Microcirculation; Peritoneal Lavage; Rats; Rats, Inbred Lew; Taurine; Thiadiazines; Treatment Outcome; Vasodilation | 2007 |
Drug therapy in a murine model of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Disease Models, Animal; Feasibility Studies; Male; Rats | 1995 |
Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis.
Topics: Administration, Topical; Animals; Biguanides; Colony Count, Microbial; Cornea; Disease Models, Animal; Disinfectants; Eye Infections, Fungal; Fusarium; Keratitis; Ophthalmic Solutions; Rabbits; Treatment Outcome | 1997 |
In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
Topics: Administration, Topical; Animals; Antibodies, Viral; Biguanides; Cattle; Cornea; Disease Models, Animal; Disinfectants; Dose-Response Relationship, Drug; Follow-Up Studies; Herpesvirus 1, Human; Keratitis, Herpetic; Ophthalmic Solutions; Rabbits; Treatment Outcome | 1997 |